Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biogen

130.67
+2.922.29%
Post-market: 130.690.0200+0.02%19:16 EDT
Volume:1.33M
Turnover:172.53M
Market Cap:19.16B
PE:12.50
High:131.26
Open:127.50
Low:127.00
Close:127.75
52wk High:207.59
52wk Low:110.04
Shares:146.61M
Float Shares:146.22M
Volume Ratio:0.71
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):10.45
EPS(LYR):11.21
ROE:9.13%
ROA:5.62%
PB:1.09
PE(LYR):11.66

Loading ...

Zurzuvae® (Zuranolone) Receives Positive Opinion From Chmp for the Treatment of Women With Postpartum Depression

THOMSON REUTERS
·
Jul 25

Biogen - Ec Decision on Zurzuvae Expected in Q3 2025

THOMSON REUTERS
·
Jul 25

Biogen Inc. Receives Positive CHMP Opinion for ZURZUVAE, Awaiting EC Approval for Postpartum Depression Treatment in EU

Reuters
·
Jul 25

Biogen’s Felzartamab Trial: A Potential Game-Changer for Kidney Transplant Recipients

TIPRANKS
·
Jul 25

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jul 23

Biogen Inc. Announces New Insights and Data from Alzheimer's Disease Trials at 2025 AAIC, Including Lecanemab and BIIB080 Studies

Reuters
·
Jul 22

Biogen Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jul 22

BUZZ-U.S. STOCKS ON THE MOVE-Meta, Microsoft, Pinterest

Reuters
·
Jul 22

Biogen’s Pediatric RRMS Study Completion: Market Implications and Insights

TIPRANKS
·
Jul 22

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-07-21

Reuters
·
Jul 21

BUZZ-Truist downgrades Biogen, citing growth challenges, limited pipeline upside

Reuters
·
Jul 21

Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm

Reuters
·
Jul 21

BRIEF-Biogen Announces $2 Billion Manufacturing Investment In North Carolina

Reuters
·
Jul 21

Fastly, Biogen, Kroger, Bloom, Pure: Insider Sell-Offs!

TIPRANKS
·
Jul 19

Biogen Inc. Stock Slips 2.9%, Underperforms Competitors

Dow Jones
·
Jul 19

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-07-18

Reuters
·
Jul 19

Biogen’s New Study on Felzartamab: A Potential Game-Changer for IgAN Treatment

TIPRANKS
·
Jul 19

Biogen’s New Study on MS Drug Vumerity: Key Insights for Investors

TIPRANKS
·
Jul 18

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Biogen (BIIB)

TIPRANKS
·
Jul 17

Biogen Executive Makes Significant Stock Sale

TIPRANKS
·
Jul 17